175 related articles for article (PubMed ID: 18781608)
1. Tumor suppressor gene co-operativity in compound Patched1 and suppressor of fused heterozygous mutant mice.
Svärd J; Rozell B; Toftgård R; Teglund S
Mol Carcinog; 2009 May; 48(5):408-19. PubMed ID: 18781608
[TBL] [Abstract][Full Text] [Related]
2. Loss of suppressor-of-fused function promotes tumorigenesis.
Lee Y; Kawagoe R; Sasai K; Li Y; Russell HR; Curran T; McKinnon PJ
Oncogene; 2007 Sep; 26(44):6442-7. PubMed ID: 17452975
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of familial medulloblastoma and contribution of germline PTCH1 and SUFU mutations to sporadic medulloblastoma.
Slade I; Murray A; Hanks S; Kumar A; Walker L; Hargrave D; Douglas J; Stiller C; Izatt L; Rahman N
Fam Cancer; 2011 Jun; 10(2):337-42. PubMed ID: 21188540
[TBL] [Abstract][Full Text] [Related]
4. Germline mutations in SUFU cause Gorlin syndrome-associated childhood medulloblastoma and redefine the risk associated with PTCH1 mutations.
Smith MJ; Beetz C; Williams SG; Bhaskar SS; O'Sullivan J; Anderson B; Daly SB; Urquhart JE; Bholah Z; Oudit D; Cheesman E; Kelsey A; McCabe MG; Newman WG; Evans DG
J Clin Oncol; 2014 Dec; 32(36):4155-61. PubMed ID: 25403219
[TBL] [Abstract][Full Text] [Related]
5. Differences in RNA and microRNA Expression Between PTCH1- and SUFU-mutated Medulloblastoma.
Gershanov S; Toledano H; Pernicone N; Fichman S; Michowiz S; Pinhasov A; Goldenberg-Cohen N; Listovsky T; Salmon-Divon M
Cancer Genomics Proteomics; 2021; 18(3):335-347. PubMed ID: 33893086
[TBL] [Abstract][Full Text] [Related]
6. Characteristic overexpression of the forkhead box transcription factor Foxf1 in Patched-associated tumors.
Wendling DS; Lück C; von Schweinitz D; Kappler R
Int J Mol Med; 2008 Dec; 22(6):787-92. PubMed ID: 19020777
[TBL] [Abstract][Full Text] [Related]
7. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma.
Briggs KJ; Corcoran-Schwartz IM; Zhang W; Harcke T; Devereux WL; Baylin SB; Eberhart CG; Watkins DN
Genes Dev; 2008 Mar; 22(6):770-85. PubMed ID: 18347096
[TBL] [Abstract][Full Text] [Related]
8. Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features.
Shimada Y; Katsube K; Kabasawa Y; Morita K; Omura K; Yamaguchi A; Sakamoto K
PLoS One; 2013; 8(8):e70995. PubMed ID: 23951062
[TBL] [Abstract][Full Text] [Related]
9. Serpine2/PN-1 Is Required for Proliferative Expansion of Pre-Neoplastic Lesions and Malignant Progression to Medulloblastoma.
Vaillant C; Valdivieso P; Nuciforo S; Kool M; Schwarzentruber-Schauerte A; Méreau H; Cabuy E; Lobrinus JA; Pfister S; Zuniga A; Frank S; Zeller R
PLoS One; 2015; 10(4):e0124870. PubMed ID: 25901736
[TBL] [Abstract][Full Text] [Related]
10. Loss of Trp53 promotes medulloblastoma development but not skin tumorigenesis in Sufu heterozygous mutant mice.
Heby-Henricson K; Bergström A; Rozell B; Toftgård R; Teglund S
Mol Carcinog; 2012 Sep; 51(9):754-60. PubMed ID: 21882258
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GLI1 gene activation by Patched1.
Rahnama F; Shimokawa T; Lauth M; Finta C; Kogerman P; Teglund S; Toftgård R; Zaphiropoulos PG
Biochem J; 2006 Feb; 394(Pt 1):19-26. PubMed ID: 16229683
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development.
Tostar U; Malm CJ; Meis-Kindblom JM; Kindblom LG; Toftgård R; Undén AB
J Pathol; 2006 Jan; 208(1):17-25. PubMed ID: 16294371
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and CNS defects in a mouse with targeted disruption of suppressor of fused.
Cooper AF; Yu KP; Brueckner M; Brailey LL; Johnson L; McGrath JM; Bale AE
Development; 2005 Oct; 132(19):4407-17. PubMed ID: 16155214
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory potential of postnatal treatment with cyclopamine, a hedgehog signaling inhibitor, on medulloblastoma development in Ptch1 heterozygous mice.
Matsuo S; Takahashi M; Inoue K; Tamura K; Irie K; Kodama Y; Nishikawa A; Yoshida M
Toxicol Pathol; 2014 Dec; 42(8):1174-87. PubMed ID: 24862798
[TBL] [Abstract][Full Text] [Related]
15. Retrospective family study of childhood medulloblastoma.
Ng D; Stavrou T; Liu L; Taylor MD; Gold B; Dean M; Kelley MJ; Dubovsky EC; Vezina G; Nicholson HS; Byrne J; Rutka JT; Hogg D; Reaman GH; Goldstein AM
Am J Med Genet A; 2005 May; 134(4):399-403. PubMed ID: 15759260
[TBL] [Abstract][Full Text] [Related]
16. Patched2 modulates tumorigenesis in patched1 heterozygous mice.
Lee Y; Miller HL; Russell HR; Boyd K; Curran T; McKinnon PJ
Cancer Res; 2006 Jul; 66(14):6964-71. PubMed ID: 16849540
[TBL] [Abstract][Full Text] [Related]
17. Nos2 inactivation promotes the development of medulloblastoma in Ptch1(+/-) mice by deregulation of Gap43-dependent granule cell precursor migration.
Haag D; Zipper P; Westrich V; Karra D; Pfleger K; Toedt G; Blond F; Delhomme N; Hahn M; Reifenberger J; Reifenberger G; Lichter P
PLoS Genet; 2012; 8(3):e1002572. PubMed ID: 22438824
[TBL] [Abstract][Full Text] [Related]
18. A model for PTCH1/Ptch1-associated tumors comprising mutational inactivation and gene silencing.
Uhmann A; Ferch U; Bauer R; Tauber S; Arziman Z; Chen C; Hemmerlein B; Wojnowski L; Hahn H
Int J Oncol; 2005 Dec; 27(6):1567-75. PubMed ID: 16273213
[TBL] [Abstract][Full Text] [Related]
19. Two cases of nevoid basal cell carcinoma syndrome associated with meningioma caused by a PTCH1 or SUFU germline mutation.
Kijima C; Miyashita T; Suzuki M; Oka H; Fujii K
Fam Cancer; 2012 Dec; 11(4):565-70. PubMed ID: 22829011
[TBL] [Abstract][Full Text] [Related]
20. Hedgehog signaling promotes the degradation of tumor suppressor Sufu through the ubiquitin-proteasome pathway.
Yue S; Chen Y; Cheng SY
Oncogene; 2009 Jan; 28(4):492-9. PubMed ID: 18997815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
